Shareholder Wei Xuening of Changchun Bcht Biotechnology Co., Ltd. (688276.SH) has reduced his holding by a total of 301,800 shares in the company.
Baike Biological (688276.SH) issued a statement on January 15, 2025, stating that the company has received a letter from shareholder Wei Xueling...
Changchun Bcht Biotechnology (688276.SH) announced that on January 15, 2025, the company received a notice from shareholder Mr. Wei Xuening regarding the implementation results of the reduction plan. The reduction results are as follows: Mr. Wei Xuening reduced his holdings in the company by a total of 301,800 shares through centralized bidding trading, accounting for 0.0730% of the total share capital of the company. As of the disclosure date of this announcement, the time period for this reduction plan has been completed.
Related Articles
Shenzhen Hello Tech Energy(301327.SZ): Strong performance hits record high, revenue and net profit both break through.
Johnson & Johnson's financial condition is stable, and Standard and Poor's has removed the downgrade warning.
HK Bull/Bear Outstanding Qty Ratio(52:48) | April 26th
Shenzhen Hello Tech Energy(301327.SZ): Strong performance hits record high, revenue and net profit both break through.
Johnson & Johnson's financial condition is stable, and Standard and Poor's has removed the downgrade warning.
HK Bull/Bear Outstanding Qty Ratio(52:48) | April 26th
RECOMMEND
Pan Gongsheng: Will implement a moderately loose monetary policy to promote high-quality development of the Chinese economy.
25/04/2025
Canadian Prime Minister Trudeau: No rush to reach agreement with Trump, US side eventually needs to face reality.
25/04/2025
Alphabet (GOOG.US, GOOGL.US) first quarter revenue and profits exceed expectations, driven by AI and cloud computing performance growth.
25/04/2025
